Bright Minds Biosciences Stock Performance
| DRUG Stock | USD 85.50 4.50 5.00% |
On a scale of 0 to 100, Bright Minds holds a performance score of 7. The firm shows a Beta (market volatility) of 2.06, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bright Minds will likely underperform. Please check Bright Minds' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bright Minds' price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.02 | Five Day Return 5.75 | Year To Date Return 7.84 | Ten Year Return 233.33 | All Time Return 233.33 |
Last Split Factor 1:5 | Last Split Date 2023-07-14 |
1 | MLTX LAWSUIT ALERT MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results Contact BFA Law if You Suffered Losses | 12/09/2025 |
2 | Bright Minds Biosciences Buy Rating Reaffirmed at HC Wainwright | 12/30/2025 |
3 | More than 500kg of cannabis seized at Pasir Panjang scanning station | 01/09/2026 |
4 | PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG... | 01/12/2026 |
5 | LEVI KORSINSKY, LLP NOTIFIES INVESTORS OF CLASS ACTION LAWSUIT AGAINST VISTAGEN THERAPEUTICS ALLEGING SECURITIES FRAUD IN DRUG DEVELOPMENT DISCLOSURES | 01/28/2026 |
6 | Several Bright Minds Biosciences Insiders Sell Shares Sending Potential Negative Signal - simplywall.st | 01/30/2026 |
7 | BTIG Maintains Bright Minds Biosciences With Buy Rating, Maintains Target Price 147 - | 02/02/2026 |
8 | Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | 02/10/2026 |
9 | Trump pardons 5 ex-NFL players including Jets legend Joe Klecko for crimes ranging from perjury to drug trafficking | 02/13/2026 |
10 | Baird Lowers Bright Minds Biosciences Inc. Price Target to 126, Maintains Outperform Rating Ahead of Upcoming Trials - Finviz | 02/18/2026 |
Bright Minds Relative Risk vs. Return Landscape
If you would invest 7,000 in Bright Minds Biosciences on November 28, 2025 and sell it today you would earn a total of 1,776 from holding Bright Minds Biosciences or generate 25.38% return on investment over 90 days. Bright Minds Biosciences is currently generating 0.4872% in daily expected returns and assumes 4.9056% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Bright, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bright Minds Target Price Odds to finish over Current Price
The tendency of Bright Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 85.50 | 90 days | 85.50 | about 28.45 |
Based on a normal probability distribution, the odds of Bright Minds to move above the current price in 90 days from now is about 28.45 (This Bright Minds Biosciences probability density function shows the probability of Bright Stock to fall within a particular range of prices over 90 days) .
Bright Minds Price Density |
| Price |
Predictive Modules for Bright Minds
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bright Minds Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bright Minds Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bright Minds is not an exception. The market had few large corrections towards the Bright Minds' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bright Minds Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bright Minds within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.56 | |
β | Beta against Dow Jones | 2.06 | |
σ | Overall volatility | 8.64 | |
Ir | Information ratio | 0.14 |
Bright Minds Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bright Minds for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bright Minds Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bright Minds had very high historical volatility over the last 90 days | |
| Net Loss for the year was (12.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (8.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Baird Lowers Bright Minds Biosciences Inc. Price Target to 126, Maintains Outperform Rating Ahead of Upcoming Trials - Finviz |
Bright Minds Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bright Stock often depends not only on the future outlook of the current and potential Bright Minds' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bright Minds' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.9 M | |
| Cash And Short Term Investments | 82.9 M |
Bright Minds Fundamentals Growth
Bright Stock prices reflect investors' perceptions of the future prospects and financial health of Bright Minds, and Bright Minds fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bright Stock performance.
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.16 | ||||
| Current Valuation | 788.04 M | ||||
| Shares Outstanding | 9.73 M | ||||
| Price To Book | 12.85 X | ||||
| EBITDA | (13.86 M) | ||||
| Net Income | (12.23 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 125.78 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 8.37 X | ||||
| Cash Flow From Operations | (8.69 M) | ||||
| Earnings Per Share | (2.02) X | ||||
| Market Capitalization | 884.52 M | ||||
| Total Asset | 84.42 M | ||||
| Retained Earnings | (46.58 M) | ||||
| Working Capital | 81.97 M | ||||
About Bright Minds Performance
By analyzing Bright Minds' fundamental ratios, stakeholders can gain valuable insights into Bright Minds' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bright Minds has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bright Minds has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.13) | (0.14) | |
| Return On Capital Employed | (0.15) | (0.16) | |
| Return On Assets | (0.13) | (0.14) | |
| Return On Equity | (0.13) | (0.14) |
Things to note about Bright Minds Biosciences performance evaluation
Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bright Minds had very high historical volatility over the last 90 days | |
| Net Loss for the year was (12.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (8.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Baird Lowers Bright Minds Biosciences Inc. Price Target to 126, Maintains Outperform Rating Ahead of Upcoming Trials - Finviz |
- Analyzing Bright Minds' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bright Minds' stock is overvalued or undervalued compared to its peers.
- Examining Bright Minds' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bright Minds' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bright Minds' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bright Minds' stock. These opinions can provide insight into Bright Minds' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |